Global Abuse Deterrent Formulation Technology Market

Abuse Deterrent Formulation Technology Market Insights

The global abuse deterrent formulation technology market is estimated to witness a high CAGR during the forecast period (2019-2026). The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for abuse deterrent formulation technology from the pharmaceutical industry is driving the market growth. Abuse-deterrent formulations are used to decrease the abuse, addiction, and overdose of orally prescribed opioids. The increasing use of abuse deterrent formulations for postoperative pain along with the growing incidence of diseases like cancer is also driving the market growth.

Abuse Deterrent Formulation Technology Market: By Drug Class

On the basis of drug class, the global abuse deterrent formulation technology market is segmented into opioids, antidepressants, and CNS stimulants. Opioids segment held the largest share and is projected to grow at the highest CAGR during the forecast period. Reducing misuse and abuse is one of the more interesting applications of abuse deterrent formulation. The growing use of opioids for pain has led to the increased availability of these medications in the population across the globe.

Abuse Deterrent Formulation Technology Market: By Approach

On the basis of approach, the market is segmented into physical /chemical barriers, agonist / antagonist combinations, aversion approach, prodrug approach, and abuse-deterrent drug delivery systems among others. Abuse-deterrent drug delivery systems segment held the largest market share and is projected to grow at the highest CAGR during the forecast period. Increase in abuse of controlled substances and resulting overdose deaths is correlated with significant increases in the supply of such medications, including opioids, central nervous system depressants.

Abuse Deterrent Formulation Technology Market: By Type of End Product

Based on type of end product, the abuse deterrent formulation technology market is segmented into tablets, capsules, transdermal patches, and thin films, among others. The tablet and capsules segment is dominating the market and expected to grow at the significant CAGR during the forecast period.

Abuse Deterrent Formulation Technology Market: By Region

North America is expected to dominate the market growth and is expected to grow at the highest CAGR during the forecast period. Rise in research and development activities and increase in prescription of opioid pain medication drugs is expected to boost the market growth in the region. According to the data published by Centers for Disease Control and Prevention (CDC), in 2017 more than 72,000 overdose-related deaths were reported in the United States, in which 50,000 are involved the use of an opioid. The European region is also expected to grow at the significant CAGR during the forecast period. Growing number of accidents and increasing number of operations are some of the key factors which are projected to foster market growth during the coming years in the region.

Abuse Deterrent Formulation Technology Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are Abbott Laboratories, Biogen and Pfizer among others.

Abuse Deterrent Formulation Technology Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the Abuse Deterrent Formulation Technology market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Abuse Deterrent Formulation Technology Market Share & Competitor Analysis

Some of the key players operating in the Abuse Deterrent Formulation Technology market are Bayer, TITAN Pharmaceuticals, Pfizer, Orexo, Lonza, Johnson & Johnson, Acura Pharmaceuticals, Daiichi Sankyo, ExxPharma Therapeutics, SunGen Pharma and Teva Pharmaceutical among others.

In January 2019, Pinney Associates Inc., collaborated with NMS labs to conduct and analyze vitro laboratory testing of pharmaceutical formulations to evaluate abuse-deterrent properties.